Gain Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Gain Therapeutics

11/08/2021 22:02

* Gain Therapeutics Inc  GANX.OQ  reported a quarterly adjusted
loss of 30 cents​​ per share for the quarter ended in June. The
mean expectation of two analysts for the quarter was for a loss
of 30 cents per share.
* Revenue was $89.00 thousand​;  analysts expected zero. 
* Gain Therapeutics Inc's reported EPS for the quarter was a
loss of 30 cents​.
* The mean earnings estimate of analysts had fallen by
about 29.8% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Gain Therapeutics Inc shares had fallen by 20.0% this quarter.
* The company reported a quarterly loss of $3.56 million.
* Wall Street's median 12-month price target for Gain
Therapeutics Inc is $30.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated August 11 at 09:02 p.m.  ​All
figures in US dollars unless otherwise stated